A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a multicenter, double-blind, parallel-group, placebo controlled, 2-part study to evaluate the efficacy and safety of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with cyclin-dependent kinase like-5 (CDKL5) deficiency disorder (CDD).
Epistemonikos ID: d32c8dc9f06bd8717d7c5169e684ee6d75954653
First added on: May 09, 2024